Arrivent Biopharma Inc (AVBP)
$14.87 -6.77% Close Oct 30, 2026 Live
Arrivent Biopharma stock today
Arrivent Biopharma closed at $14.87 on October 30, 2026, down 6.77% on the day. Over the past year it returned -19.5% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $693 million.
$20.00$30.00
NovJan 2026MarMayJulSep
| Period | AVBP | S&P 500 (SPY) |
|---|---|---|
| 1 month | -50.9% | -0.9% |
| 3 months | -51.5% | +2.1% |
| Year to date | -26.1% | +11.7% |
| 1 year | -19.5% | +12.4% |
Key statistics
- Market value
- $693M
- 52-week range
- $14.87 to $34.74
- Next report
- Nov 16, 2026 (estimated)
About Arrivent Biopharma
Develops biopharmaceutical treatments.
Sector: Health Care
More on Arrivent Biopharma
- Returns: what $1,000 became$1,000 one year ago is $805.09 today
No forecast, no recommendation. This page describes Arrivent Biopharma Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.